# Genentech, Inc., South San Francisco, CA – FDA Inspections

Source: https://www.keypedia.com/companies/genentech-inc/709aa262-e8df-42fa-bec6-02673e7f52ec

> Inspection records and compliance data for Genentech, Inc. in South San Francisco, California. 35 FDA inspections on record, 2 Form 483s, last inspected August 04, 2026.

---

## Details

- Name: Genentech, Inc.
- FEI Number: 2917293
- Facility Type: Manufacturer
- Address Line 1: 1 Dna Way
- City: South San Francisco
- State: California
- Zip Code: 94080
- Country Name: United States
- Address: 1 Dna Way, South San Francisco, California 94080, United States
- Country: United States

## Related Documents

- [CRL - Genentech, Inc. - Unknown Date](https://www.keypedia.com/records/crl/genentech-inc/82cfc039-6c70-459b-ad38-2e0ed36626fa) — source: FDA, date: Invalid Date
- FDA Inspection 1332732 - Genentech, Inc. - 2026-08-04 — source: FDA, date: August 4, 2026
- FDA Inspection 1322404 - Genentech, Inc. - 2026-05-15 — source: FDA, date: May 15, 2026
- FDA Inspection 1314654 - Genentech, Inc. - 2026-04-07 — source: FDA, date: April 7, 2026
- FDA Inspection 1263573 - Genentech, Inc. - 2025-04-21 — source: FDA, date: April 21, 2025
- FDA Inspection 1263573 - Genentech, Inc. - 2025-04-21 — classification: No Action Indicated (NAI), source: FDA, date: April 21, 2025
- [FDA Inspection 1236964 - Genentech, Inc. - 2024-05-02](https://www.keypedia.com/records/fda_inspections/genentech-inc/d7fa8583-d22f-424b-8e09-2c1404f53842) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 2, 2024
- FDA Inspection 1236964 - Genentech, Inc. - 2024-05-02 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 2, 2024
- [FDA Inspection 1235655 - Genentech, Inc. - 2024-03-20](https://www.keypedia.com/records/fda_inspections/genentech-inc/6b6012ce-24be-471f-8d57-85bb92f5fb25) — classification: No Action Indicated (NAI), source: FDA, date: March 20, 2024
- [483 - Genentech, Inc. - 2024-03-12](https://www.keypedia.com/records/483/genentech-inc/7887b305-0de6-472c-b596-8cbd94e8d300) — source: FDA, date: March 12, 2024
- [FDA Inspection 1233203 - Genentech, Inc. - 2024-03-12](https://www.keypedia.com/records/fda_inspections/genentech-inc/c630a432-31f9-476d-9f0d-9c7a9ed953d0) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 12, 2024
- [483 - Genentech, Inc. - 2023-08-11](https://www.keypedia.com/records/483/genentech-inc/ce85e9f0-3331-495a-b1b4-a7e2df5fa79b) — source: FDA, date: August 11, 2023
- [FDA Inspection 1214575 - Genentech, Inc. - 2023-08-11](https://www.keypedia.com/records/fda_inspections/genentech-inc/84a034a5-344a-46c2-9b20-5a05a08e407b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 11, 2023
- [483 - Genentech, Inc. - 2023-01-31](https://www.keypedia.com/records/483/genentech-inc/e020acbc-f66e-4314-a8bc-c156ef8c9a94) — source: FDA, date: January 31, 2023
- [EIR - Genentech, Inc. - 2022-10-07](https://www.keypedia.com/records/eir/genentech-inc/c790563c-45ba-439c-8c24-6cd1f80fcf3f) — source: FDA, date: October 7, 2022
- [483 - Genentech, Inc. - 2022-05-26](https://www.keypedia.com/records/483/genentech-inc/3b630c1e-0dc5-44a8-a456-256f25c6a163) — source: FDA, date: May 26, 2022
- [EIR - Genentech, Inc. - 2016-09-16](https://www.keypedia.com/records/eir/genentech-inc/2b4ed0c8-e5f3-40aa-84e2-72d27b55d3b8) — source: FDA, date: September 16, 2016
- [483 - Genentech, Inc. - 2011-09-27](https://www.keypedia.com/records/483/genentech-inc/18f90c1b-4f69-4c48-99f7-a22fc019324c) — source: FDA, date: September 27, 2011

## Related Companies

- [Reliance Life Sciences Private Limited](https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f)
- [Aprecia Pharmaceuticals LLC](https://www.keypedia.com/companies/aprecia-pharmaceuticals-llc/126049a3-6c3d-4616-8d44-006827a308c3)
- [Shionogi Pharma Co., Ltd.](https://www.keypedia.com/companies/shionogi-pharma-co-ltd/bb3e5dcd-52f9-4971-9747-4c04b63ba0fa)
- [Taro Pharmaceutical Industries, Ltd.](https://www.keypedia.com/companies/taro-pharmaceutical-industries-ltd/75bff305-a575-43eb-9c35-401fed5479be)
- [Cilag AG](https://www.keypedia.com/companies/cilag-ag/acb7f670-89b9-4e40-a784-ed06b0282362)
- [Shandong Anxin Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/shandong-anxin-pharmaceutical-co-ltd/1bbdc465-0634-4e76-994f-a57ad864fc33)
- [F. Hoffmann - La Roche Ltd.](https://www.keypedia.com/companies/f-hoffmann-la-roche-ltd/622e8fa3-95f3-4ed9-a1bd-99dc0748f273)
- [Actavis Elizabeth LLC, A Company of Teva](https://www.keypedia.com/companies/actavis-elizabeth-llc-a-company-of-teva/c4a12fda-d6c3-4ad3-bac5-cc2b5695950e)
- [Merck Serono SA](https://www.keypedia.com/companies/merck-serono-sa/11522eec-8d30-492a-90ba-09b167899bdc)
- [Nordmark Arzneimittel GMBH & Co. KG](https://www.keypedia.com/companies/nordmark-arzneimittel-gmbh-co-kg/871eb270-8517-4646-923a-b4d2eb0ea73b)

## Related Officers

- [company_representative](https://www.keypedia.com/people/lorraine-k-fay/0481f8a2-7630-4b31-b50f-4e6b652947a1)
- [company_representative](https://www.keypedia.com/people/daniel-oday/2784a05c-ad91-4437-8e4c-0d46265484d4)
- [Regulatory Scientist at FDA](https://www.keypedia.com/people/yi-wang/f5355ae0-ae28-452f-829a-786b7ebc4791)
- [Senior Lead Reviewer and Intercenter Consult Team Leader](https://www.keypedia.com/people/nayan-j-patel/0436f014-4b1b-4e54-8df0-576d51a354b2)
- [investigator](https://www.keypedia.com/people/dustin-r-abaonza/0a9994bd-d6ab-47cc-8f1b-5bf4d10bd852)
